Low Level Central Nervous System (CNS) Disease in Acute Lymphoid Leukemia (ALL): Does it Impact Outcome?

被引：0
|
作者：
Dreyer, Z. [1 ]
Marcogliese, A. [1 ]
Hashmi, S. [1 ]
Margolin, J. [1 ]
Kamdar, K. [1 ]
Brackett, J. [1 ]
Rabin, K. [1 ]
Stevens, A. [1 ]
Horton, T. [1 ]
Redell, R. [1 ]
Rouce, R. [1 ]
Yi, J. [1 ]
Schafer, E. [1 ]
Armstrong, T. [1 ]
Kollar, D. [1 ]
Sealy, L. [1 ]
Gramatges, M. [1 ]
Steuber, C. [1 ]
机构：
[1] Baylor Coll Med, Pediat, Houston, TX 77030 USA
来源：
PEDIATRIC BLOOD & CANCER | 2018年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO-038
引用
收藏
页码：S112 / S112
页数：1
相关论文
共 50 条
  • [21] Central nervous system disease in childhood acute lymphoblastic leukemia
    Jin, Mingwei
    An, Qi
    Xu, Shumei
    MINERVA PEDIATRICA, 2019, 71 (05) : 470 - 474
  • [22] PSEUDO CENTRAL NERVOUS-SYSTEM (CNS) LEUKEMIA
    DAVID, RB
    MAURER, HM
    SHUMWAY, CN
    PEDIATRIC RESEARCH, 1973, 7 (04) : 354 - 354
  • [23] Central nervous system disease in pediatric acute myeloid leukemia
    Gruber, Tanja A.
    Zwaan, C. Michel
    PEDIATRIC BLOOD & CANCER, 2017, 64 (12)
  • [24] Central nervous system (CNS) involvement has an adverse impact on survival in newly diagnosed adult acute lymphoblastic leukemia (ALL) assessed by flow cytometry
    Daniela Cordova-Serrano, Rosana
    Almanza-Huante, Emmanuel
    Fernandez-Sanchez, Emmanuel
    Hernandez-Alcantara, Areli
    Espinosa-Bautista, Karla
    LEUKEMIA & LYMPHOMA, 2021, 62 (13) : 3264 - 3270
  • [25] Liposomal cytarabine for central nervous system (CNS) relapse in acute promyelocytic leukemia (APL).
    Castagnola, Carlo
    Lunghi, M.
    Calatroni, S.
    Lazzarino, M.
    BLOOD, 2006, 108 (11) : 227B - 227B
  • [26] Origin of a central nervous system lymphoid neoplasm in an immunocompromised host with acute lymphoblastic leukemia
    Mayer, SP
    Jayabose, S
    Tugal, O
    Ozkaynak, M
    Rosenblum-Vos, L
    Sandoval, C
    LEUKEMIA & LYMPHOMA, 2002, 43 (09) : 1881 - 1884
  • [27] Outcome of the Rotterdam-84 CNS-ALL chemotherapy protocol without radiotherapy for isolated central nervous system relapsed acute lymphoblastic leukemia.
    Beishuizen, A
    Aarsen, FK
    van Dongen, JEWM
    Streng, IC
    Pieters, R
    Hahlen, K
    BLOOD, 2004, 104 (11) : 539A - 540A
  • [28] CENTRAL NERVOUS SYSTEM (CNS) INVOLVEMENT AT DIAGNOSIS DOES NOT ADVERSELY AFFECT THE OUTCOME OF HIGH-DOSE CHEMOTHERAPY AND TRANSPLANT FOR PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML)
    Petropoulos, D.
    Giralt, S. A.
    Andersson, B. S.
    Chan, K.
    Rondon, G.
    Popat, U. R.
    Hosing, C.
    Alousi, A. M.
    Champlin, R. E.
    de Lima, M. J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (02) : 61 - 62
  • [29] THE RISK OF CENTRAL NERVOUS-SYSTEM (CNS) RELAPSE AFTER BMT FOR PATIENTS WITH ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) IN REMISSION
    GANEM, G
    KUENTZ, M
    BERNAUDIN, F
    GHARBI, A
    CORDONNIER, C
    LEMERLE, S
    VINCI, G
    LEBOURGEOIS, JP
    VERNANT, JP
    BONE MARROW TRANSPLANTATION, 1988, 3 : 193 - 193
  • [30] Central Nervous System Leukemia in Acute Myeloid Leukemia
    Altriki, Mohamad
    Cheng, Meng-Ru
    Fauble, Veena
    Khera, Nandita
    Leis, Jose
    Mesa, Ruben A.
    Noel, Pierre
    Slack, James L.
    Tibes, Raoul
    Sproat, Lisa Ostrosky
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (02) : S151 - S151
12345